Guido Oelkers
business executive
Guido Oelkers has been named the successor to Uğur Şahin as the CEO of BioNTech, effective no later than February 1, 2027. He has an extensive background in the biopharma sector, having previously led Swedish Orphan Biovitrum (Sobi) and worked for Hoechst AG in the 1990s.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Germany:
Guido Oelkers will succeed Uğur Şahin as CEO of Biontech by February 1, 2027.
5